Evidence map›Paper›PMID 41947880›Full record

ArticlePCN reports : psychiatry and clinical neurosciences2026

Dystrophinopathy with a

Shusei Arafuka, Youta Torii, Ayako Miwa, Itaru Kushima, Hirotaka Sekiguchi, Hiroshige Fujishiro, Chikako Habuchi, Hiroaki Miyahara, Yosuke Kawai, Ran Wei and 6 more

Abstract read
In one paragraph

Article in PCN reports : psychiatry and clinical neurosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Shusei ArafukaDepartment of Psychiatry Nagoya University Graduate School of Medicine Nagoya Aichi Japan.ORCID https://orcid.org/0000-0002-8700-8106
Youta ToriiDepartment of Psychiatry Nagoya University Graduate School of Medicine Nagoya Aichi Japan.ORCID https://orcid.org/0000-0002-4202-0638
Ayako MiwaMoriyama General Mental Hospital Nagoya Aichi Japan.
Itaru KushimaDepartment of Psychiatry Nagoya University Graduate School of Medicine Nagoya Aichi Japan.
Hirotaka SekiguchiDepartment of Psychiatry Okehazama Hospital Fujita Mental Care Center Toyoake Aichi Japan.
Hiroshige FujishiroDepartment of Psychiatry Nagoya University Graduate School of Medicine Nagoya Aichi Japan.ORCID https://orcid.org/0000-0001-9822-5432
Chikako HabuchiAichi Psychiatric Medical Center Nagoya Aichi Japan.
Hiroaki MiyaharaDepartment of Neuropathology, Institute for Medical Science of Aging Aichi Medical University Nagakute Aichi Japan.
Yosuke KawaiGenome Medical Science Project, Research Institute National Center for Global Health and Medicine Tokyo Japan.
Ran WeiGenome Medical Science Project, Research Institute National Center for Global Health and Medicine Tokyo Japan.
Katsushi TokunagaGenome Medical Science Project, Research Institute National Center for Global Health and Medicine Tokyo Japan.
Norio OzakiPathophysiology of Mental Disorders Nagoya University Graduate School of Medicine Nagoya Aichi Japan.
Mari YoshidaDepartment of Neuropathology, Institute for Medical Science of Aging Aichi Medical University Nagakute Aichi Japan.
Shuji IritaniDepartment of Psychiatry Nagoya University Graduate School of Medicine Nagoya Aichi Japan.
Yasushi IwasakiDepartment of Neuropathology, Institute for Medical Science of Aging Aichi Medical University Nagakute Aichi Japan.
Masashi IkedaDepartment of Psychiatry Nagoya University Graduate School of Medicine Nagoya Aichi Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Mutations in Case Presentation: The patient exhibited a developmental delay, intellectual disability, and schizophrenia, and died at 66 years of age from renal and heart failure. A copy number variation analysis and whole-genome sequencing revealed a heterozygous deletion in chrX:31774440-31859356 (hg38), encompassing exons 49 and 50 of Conclusion: The neuropathological findings in this case and in previous studies of Duchenne muscular dystrophy partially overlap with those of schizophrenia. To elucidate the pathogenesis and relationship between schizophrenia and

Indexed as

Duchenne muscular dystrophydystrophinintellectual disabilitymanifesting carrierschizophrenia

Identifiers

PMID41947880
PMCPMC13052307

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.